98 related articles for article (PubMed ID: 1703370)
1. Effects of specific monoclonal antibodies on La Crosse virus neutralization: aggregation, inactivation by Fab fragments, and inhibition of attachment to baby hamster kidney cells.
Kingsford L; Boucquey KH; Cardoso TP
Virology; 1991 Feb; 180(2):591-601. PubMed ID: 1703370
[TBL] [Abstract][Full Text] [Related]
2. Enhanced neutralization of La Crosse virus by the binding of specific pairs of monoclonal antibodies to the G1 glycoprotein.
Kingsford L
Virology; 1984 Jul; 136(2):265-73. PubMed ID: 6205500
[TBL] [Abstract][Full Text] [Related]
3. Biological activities of monoclonal antibodies reactive with antigenic sites mapped on the G1 glycoprotein of La Crosse virus.
Kingsford L; Ishizawa LD; Hill DW
Virology; 1983 Sep; 129(2):443-55. PubMed ID: 6194614
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies specific for the G1 glycoprotein of La Crosse virus that react with other California serogroup viruses.
Kingsford L; Boucquey KH
J Gen Virol; 1990 Mar; 71 ( Pt 3)():523-30. PubMed ID: 2179465
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of rhinovirus attachment by neutralizing monoclonal antibodies and their Fab fragments.
Colonno RJ; Callahan PL; Leippe DM; Rueckert RR; Tomassini JE
J Virol; 1989 Jan; 63(1):36-42. PubMed ID: 2535737
[TBL] [Abstract][Full Text] [Related]
6. Two influenza A virus-specific Fabs neutralize by inhibiting virus attachment to target cells, while neutralization by their IgGs is complex and occurs simultaneously through fusion inhibition and attachment inhibition.
Edwards MJ; Dimmock NJ
Virology; 2000 Dec; 278(2):423-35. PubMed ID: 11118365
[TBL] [Abstract][Full Text] [Related]
7. Two monoclonal antibodies against La Crosse virus show host-dependent neutralizing activity.
Grady LJ; Kinch W
J Gen Virol; 1985 Dec; 66 ( Pt 12)():2773-6. PubMed ID: 4067586
[TBL] [Abstract][Full Text] [Related]
8. Different mechanisms of antibody-mediated neutralization of parvoviruses revealed using the Fab fragments of monoclonal antibodies.
Nelson CD; Palermo LM; Hafenstein SL; Parrish CR
Virology; 2007 May; 361(2):283-93. PubMed ID: 17217977
[TBL] [Abstract][Full Text] [Related]
9. Bacterial expression of neutralizing mouse monoclonal antibody Fab fragments to Hantaan virus.
Liang M; Chu YK; Schmaljohn C
Virology; 1996 Mar; 217(1):262-71. PubMed ID: 8599211
[TBL] [Abstract][Full Text] [Related]
10. Efficient neutralization of foot-and-mouth disease virus by monovalent antibody binding.
Verdaguer N; Fita I; Domingo E; Mateu MG
J Virol; 1997 Dec; 71(12):9813-6. PubMed ID: 9371652
[TBL] [Abstract][Full Text] [Related]
11. Is bivalent binding of monoclonal antibodies to different antigenic areas on the hemagglutinin of influenza virus required for neutralization of viral infectivity?
Yoden S; Kida H; Yanagawa R
Arch Virol; 1985; 85(3-4):209-16. PubMed ID: 2411245
[TBL] [Abstract][Full Text] [Related]
12. Evidence for three separate antigenic sites on the G1 protein of La Crosse Virus.
Grady LJ; Sanders ML; Campbell WP
Virology; 1983 Apr; 126(1):395-7. PubMed ID: 6189289
[TBL] [Abstract][Full Text] [Related]
13. A haemagglutinin (HA1)-specific FAb neutralizes influenza A virus by inhibiting fusion activity.
Edwards MJ; Dimmock NJ
J Gen Virol; 2001 Jun; 82(Pt 6):1387-1395. PubMed ID: 11369883
[TBL] [Abstract][Full Text] [Related]
14. Variations in the neutralizing and haemagglutination-inhibiting activities of five influenza A virus-specific IgGs and their antibody fragments.
Schofield DJ; Stephenson JR; Dimmock NJ
J Gen Virol; 1997 Oct; 78 ( Pt 10)():2431-9. PubMed ID: 9349461
[TBL] [Abstract][Full Text] [Related]
15. Identification of chimpanzee Fab fragments by repertoire cloning and production of a full-length humanized immunoglobulin G1 antibody that is highly efficient for neutralization of dengue type 4 virus.
Men R; Yamashiro T; Goncalvez AP; Wernly C; Schofield DJ; Emerson SU; Purcell RH; Lai CJ
J Virol; 2004 May; 78(9):4665-74. PubMed ID: 15078949
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies against La Crosse virus.
Grady LJ; Srihongse S; Grayson MA; Deibel R
J Gen Virol; 1983 Aug; 64 (Pt 8)():1699-704. PubMed ID: 6192204
[TBL] [Abstract][Full Text] [Related]
17. The effect of proteolytic cleavage of La Crosse virus G1 glycoprotein on antibody neutralization.
Kingsford L; Hill DW
J Gen Virol; 1983 Oct; 64 (Pt 10)():2147-56. PubMed ID: 6352863
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies directed against the envelope glycoproteins of La Crosse virus.
Ludwig GV; Israel BA; Christensen BM; Yuill TM; Schultz KT
Microb Pathog; 1991 Dec; 11(6):411-21. PubMed ID: 1795631
[TBL] [Abstract][Full Text] [Related]
19. Epitopes of the G1 glycoprotein of La Crosse virus form overlapping clusters within a single antigenic site.
Najjar JA; Gentsch JR; Nathanson N; Gonzalez-Scarano F
Virology; 1985 Jul; 144(2):426-32. PubMed ID: 2414920
[TBL] [Abstract][Full Text] [Related]
20. Isolation of human monoclonal antibodies that neutralize human rotavirus.
Higo-Moriguchi K; Akahori Y; Iba Y; Kurosawa Y; Taniguchi K
J Virol; 2004 Apr; 78(7):3325-32. PubMed ID: 15016854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
